US Bancorp’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$991K Sell
7,673
-267
-3% -$38.4K ﹤0.01% 1152
2025
Q4
$1.13M Buy
7,940
+2,531
+47% +$339K ﹤0.01% 1096
2025
Q3
$649K Buy
5,409
+1,623
+43% +$206K ﹤0.01% 1364
2025
Q2
$500K Sell
3,786
-65
-2% -$8.81K ﹤0.01% 1503
2025
Q1
$535K Buy
3,851
+19
+0.5% +$2.95K ﹤0.01% 1440
2024
Q4
$595K Buy
3,832
+315
+9% +$53.3K ﹤0.01% 1406
2024
Q3
$641K Buy
3,517
+17
+0.5% +$2.52K ﹤0.01% 1362
2024
Q2
$416K Buy
3,500
+402
+13% +$42.3K ﹤0.01% 1602
2024
Q1
$332K Buy
3,098
+476
+18% +$47.3K ﹤0.01% 1742
2023
Q4
$262K Buy
2,622
+1,033
+65% +$101K ﹤0.01% 1879
2023
Q3
$189K Sell
1,589
-132
-8% -$19.7K ﹤0.01% 1854
2023
Q2
$307K Sell
1,721
-223
-11% -$40.9K ﹤0.01% 1665
2023
Q1
$321K Sell
1,944
-192
-9% -$33K ﹤0.01% 1646
2022
Q4
$336K Sell
2,136
-139
-6% -$21.2K ﹤0.01% 1599
2022
Q3
$342K Sell
2,275
-812
-26% -$135K ﹤0.01% 1581
2022
Q2
$507K Buy
3,087
+362
+13% +$69.7K ﹤0.01% 1432
2022
Q1
$606K Sell
2,725
-430
-14% -$96.3K ﹤0.01% 1446
2021
Q4
$748K Sell
3,155
-109
-3% -$25.5K ﹤0.01% 1334
2021
Q3
$762K Sell
3,264
-358
-10% -$75.1K ﹤0.01% 1328
2021
Q2
$746K Buy
3,622
+355
+11% +$73K ﹤0.01% 1352
2021
Q1
$670K Sell
3,267
-502
-13% -$106K ﹤0.01% 1350
2020
Q4
$809K Sell
3,769
-579
-13% -$112K ﹤0.01% 1195
2020
Q3
$794K Sell
4,348
-719
-14% -$135K ﹤0.01% 1093
2020
Q2
$934K Sell
5,067
-618
-11% -$123K ﹤0.01% 985
2020
Q1
$1.15M Sell
5,685
-643
-10% -$124K ﹤0.01% 844
2019
Q4
$1.18M Sell
6,328
-1,180
-16% -$203K ﹤0.01% 984
2019
Q3
$1.2M Sell
7,508
-961
-11% -$191K ﹤0.01% 950
2019
Q2
$2.13M Sell
8,469
-634
-7% -$147K 0.01% 753
2019
Q1
$2.18M Sell
9,103
-14
-0.2% -$3.36K 0.01% 733
2018
Q4
$2.09M Sell
9,117
-544
-6% -$134K 0.01% 722
2018
Q3
$2.73M Sell
9,661
-75
-0.8% -$22K 0.01% 693
2018
Q2
$2.86M Sell
9,736
-732
-7% -$200K 0.01% 669
2018
Q1
$2.64M Sell
10,468
-1,353
-11% -$318K 0.01% 694
2017
Q4
$2.55M Sell
11,821
-1,978
-14% -$400K 0.01% 696
2017
Q3
$2.56M Sell
13,799
-1,906
-12% -$332K 0.01% 692
2017
Q2
$2.71M Buy
15,705
+670
+4% +$107K 0.01% 659
2017
Q1
$2.29M Buy
15,035
+2,124
+16% +$310K 0.01% 721
2016
Q4
$1.9M Sell
12,911
-226
-2% -$32.7K 0.01% 775
2016
Q3
$1.66M Buy
13,137
+5,123
+64% +$618K 0.01% 797
2016
Q2
$903K Sell
8,014
-916
-10% -$95.1K ﹤0.01% 1057
2016
Q1
$929K Sell
8,930
-981
-10% -$93.8K ﹤0.01% 1014
2015
Q4
$1.12M Sell
9,911
-286
-3% -$31.6K ﹤0.01% 901
2015
Q3
$1.12M Sell
10,197
-1,571
-13% -$168K ﹤0.01% 902
2015
Q2
$1.13M Buy
11,768
+540
+5% +$50.5K ﹤0.01% 959
2015
Q1
$1.05M Buy
11,228
+177
+2% +$15.5K ﹤0.01% 994
2014
Q4
$905K Sell
11,051
-3,778
-25% -$290K ﹤0.01% 1037
2014
Q3
$952K Sell
14,829
-504
-3% -$30.9K ﹤0.01% 1006
2014
Q2
$933K Buy
15,333
+540
+4% +$31.9K ﹤0.01% 1023
2014
Q1
$885K Sell
14,793
-151
-1% -$9.3K ﹤0.01% 1032
2013
Q4
$952K Sell
14,944
-4,278
-22% -$275K ﹤0.01% 947
2013
Q3
$1.31M Sell
19,222
-1,508
-7% -$108K 0.01% 795
2013
Q2
$1.49M Buy
+20,730
New +$1.37M 0.01% 705

Other funds holding ICUI

US Bancorp's ICUI Position: Q1 2026 in Review

US Bancorp reduced its ICU Medical (ICUI) stake by 3.4% in Q1 2026, selling an estimated $38.4K and leaving 7,673 shares worth $991K. The position accounts for ﹤0.01% of the portfolio, ranked #1152.

US Bancorp first reported a position in ICUI in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.86M in Q2 2018. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • US Bancorp held 7,673 shares of ICU Medical worth $991K as of Q1 2026.
  • US Bancorp sold 267 ICU Medical shares in Q1 2026, an estimated $38.4K.
  • ICU Medical made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #1152 holding.
  • US Bancorp first reported a position in ICU Medical in Q2 2013 and has held it in 52 quarters since.
  • US Bancorp's ICU Medical position peaked at $2.86M in Q2 2018.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.